Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
27 May 2011

IN THIS ISSUE
EMA criticism
Takeda and Nycomed
Drug spending
Medicines for women

 
EMA hits back at transparency criticism
Following recent accusations that the EMA puts companies' commercial interests ahead of public safety, the EMA has responded by emphasising recent agency initiatives at the agency to improve data access.. More...
 
Takeda to acquire Nycomed for €9.6 billion
With the aim of increasing its presence in European and emerging markets, Takeda Pharmaceutical has agreed to acquire Nycomed for €9.6 billion ($13.7 billion), excluding Nycomed's US dermatology business. More...
 
IMS predicts slowed growth in drug spending
Global spending on medicines will total almost $1.1 trillion by 2015, according to a study by the IMS Institute for Healthcare Informatics published last week; however, spending will be slower than the 6.2% annual growth rate of the past five years. More...
 
More than 800 medicines in development for diseases affecting women
The Pharmaceutical Research and Manufacturers of America reports that US pharmaceutical research and biotechnology companies are developing 851 medicines for diseases that disproportionately affect American women. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
 

Latest blog posts
Will Senator Kohl thwart drugmakers' strategy for survival?
Branded medicine use in decline
Eli Lilly's new biotech company builds on alliance strategy
More blog posts

Latest peer-reviewed research
Gelatin capsule shell cross-linking
'Capability of the art' versus 'fit for use'
Pharmaceutical excipients for hot-melt extrusion
More articles

Upcoming events
Chemspec Europe 2011 (15–15 June | Switzerland)
Pharma Brand Summit 2011 (27–29 June | Switzerland)
Dry Powder Inhalers: The Next 35 Years (29–30 June | UK)
More events

Product/Service Profiles
Flexicon Liquid Filling

FF30 Aseptic Filling and Capping Machine
The new Flexicon FF30 aseptic filling and capping machine delivers a consistent level of production quality which is impossible to maintain with manual assembly of bottles and caps. Read more

 
GEA Pharma Systems

Contained pilot granulation system
GEA Pharma Systems – Aeromatic-Fielder™ has launched a complete production plant that takes the process from dispensed raw materials to finished tablet. Read More

 


Survey
Does your company apply continuous processing in any projects in your manufacturing operations?
No 59%
 
Yes, in solid dose manufacturing 20%
     
Yes, in parenteral drug manufacturing 6%
     
Yes, in manufacturing small-molecule APIs 12%
     
Yes, in manufacturing biologic-based APIs 3%

This week we would like to know...

Do you think shared audits can be a tool to help manage the pharmaceutical supply chain?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.